the pricey drug.
WHO has, like the United States and the European Union, already recommended its use to treat severe Covid-19 in hospital settings. "The listings should pave the way for more companies coming forward to seek WHO prequalification, thereby increasing the number of quality-assured products and creating competition leading to potentially lower prices," WHO said in a statement.
Prior to tocilizumab, the WHO has prequalified three different compositions for the steroid dexamethasone for treating Covid-19, as well as Gilead's antiviral remdesivir, although that prequalification has since been suspended.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.